Susquehanna International Group, LLP Sio Gene Therapies Inc. Transaction History

Susquehanna International Group, LLP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.28 - $0.44 $26,708 - $41,970	95,387 New	95,387 $41,000
Q2 2022 Aug 15, 2022	SELL	$0.25 - $0.73 $1,136 - $3,318	-4,546 Reduced 7.36%	57,187 $20,000
Q1 2022 May 16, 2022	SELL	$0.55 - $1.47 $26,450 - $70,695	-48,092 Reduced 43.79%	61,733 $41,000
Q4 2021 Feb 14, 2022	BUY	$1.29 - $2.36 $106,120 - $194,143	82,264 Added 298.48%	109,825 $142,000
Q3 2021 Nov 15, 2021	BUY	$1.81 - $2.7 $23,415 - $34,929	12,937 Added 88.46%	27,561 $60,000
Q2 2021 Aug 11, 2021	SELL	$2.07 - $2.89 $202,688 - $282,980	-97,917 Reduced 87.01%	14,624 $40,000
Q1 2021 May 17, 2021	SELL	$2.34 - $3.44 $197,765 - $290,731	-84,515 Reduced 42.89%	112,541 $294,000
Q4 2020 Feb 16, 2021	BUY	$1.91 - $5.63 $376,376 - $1.11 Million	197,056 New	197,056 $548,000

147K

Ticker SIOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,975,200
Description
Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical S...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.